Search Results - "Mumot, M"

Proton range verification using a range probe: definition of concept and initial analysis by Mumot, M, Algranati, C, Hartmann, M, Schippers, J M, Hug, E, Lomax, A J

“…Proton therapy can be particularly sensitive to changes or errors in range. Thus, methods for the in vivo measurement of range could be of great use to improve…”
Get more information

OC-0160: Five years of experience with patient specific verifications of spot scanned IMPT by Trnková, P, Gomà, C, Mumot, M, Lomax, A

Get full text

OC-0250: Proton beam monitor chambers calibration: Faraday cup vs ionization chamber by Gomà, C, Lorentini, S, Trnková, P, Mumot, M, Hrbácek, J, König, S, Meer, D, Safai, S

Get full text

PO-1985 The importance of spot distribution and its influence on the LEM/MKM model relationship in CIRT by Gora, J., Fossati, P., Mumot, M., Shamshad, M., Stock, M., Carlino, A.

Get full text

PO-1097 Carbon ion radiotherapy (CIRT) at MedAustron: early clinical experience by Fossati, P., Stock, M., Pelak, M., Martino, G., Tubin, S., Góra, J., Mock, U., Daniel, M., Georg, P., Mumot, M., Reschl, C., Carlino, A., Hug, E.

Get full text

P03.06.B Proton irradiation (PT) for benign meningiomas, Grade I clinical experience of the first 100 patients from REGI-MA-002015 by Lütgendorf-Caucig, C, Hug, E, Pelak, M, Flechl, B, Mock, U, Fossati, P, Mumot, M, Carlino, A, Georg, P

“…Abstract Background Meningiomas are the most common CNS tumors and the majority is regarded as benign. However, a subset of patients presents with complex…”
Get full text

P07.10.A CLINICAL OUTCOMES OF SPOT-SCANNING PROTON BEAM THERAPY FOR IDH-MUTANT CNS WHO GRADE 2 AND 3 GLIOMA by Pelak, M J, Lütgendorf-Caucig, C, Flechl, B, Mock, U, Mozes, P, Fossati, P, Georg, P, Fussl, C, Surböck, B, Mumot, M, Stock, M, Wolfsberger, S, Urbanic Purkart, T, Calabek-Wohinz, B, Hug, E

“…Abstract BACKGROUND The latest WHO brain tumour classification puts utmost emphasis on prognostic significance of isocitrate dehydrogenase (IDH) mutation…”
Get full text

OC-0076 Meningioma I° involves optical structures: does proton therapy lead to subjective changes in vision? by Flechl, B., Konrath, L., Hug, E., Lütgendorf-Caucig, C., Achtaewa, M., Pelak, M., Schallerbauer-Peter, A., Zimmermann, J., Sebek, M., Svardal, C., Mumot, M., Mock, U., Konstantinovic, R., Fossati, P., Georg, P.

Get full text

OC-0491: Quality assurance of a novel table mounted imaging device integrated in a patient positioning system by Utz, A., Ableitinger, A., Zechner, A., Mumot, M., Teichmeister, M., Steininger, P., Deutschmann, H., Stock, M.

Get full text

46. Medical commissioning of a Light Ion Beam Therapy facility: The MedAustron experience of starting up using innovative technology by Stock, M., Grevillot, L., Kragl, G., Ableitinger, A., Palmans, H., Osorio, J., Böhlen, T., Gora, J., Hopfgartner, J., Letellier, V., Dreindl, R., Fuchs, H., Knäusl, B., Carlino, A., Utz, A., Mumot, M., Zechner, A., Elia, A., Vatnitsky, S.

“…One of the methods of acquiring equipment for a Light Ion Beam Therapy (LIBT) facility is to establish collaboration between the customer and one or more…”
Get full text

325. Boron Neutron Capture Therapy by Mumot, M.

“…Boron Neutron Capture Therapy (BNCT) is a unique form of radiotherapy that carries a potential for a significant improvement in therapeutic gain. That…”
Get full text